Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01438255

Enrollment

274

Registered

2011-09-22

Start date

2010-07-31

Completion date

Unknown

Last updated

2012-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

This is a prospective, non-comparative, open, observational study.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 18 Years

Healthy volunteers

Inclusion criteria

* Children who is prescribed with ciclesonide for asthma

Exclusion criteria

* Subjects with contraindications to ciclesonide use * Subjects with clinically relevant concomitant disease that could compromise the patient's safety should not be included in this study.

Design outcomes

Primary

Measure	Time frame
Asthma control day	12weeks

Secondary

Measure	Time frame
Morning peak expiratory flow	12weeks
asthma exacerbation	12weeks
The number of Reliever use	12weeks
Asthma symptom score	12weeks
Number of Participants with Adverse Events	12weeks

Countries

South Korea

Outcome results